SCREENING IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ELIGIBLE HEART FAILURE PATIENTS WITH I-123 METAIODOBENZYLGUANIDINE IMAGING VERSUS NO SCREENING: AN ECONOMIC MODEL COMPARING COSTS AND OUTCOMES | Publicación